Home  >  Health Encyclopedia  >  Cancer Care

Health Encyclopedia

 

Cancer Care



FDA-Approved Drugs

FDA-Approved Drugs

Zolinza (vorinostat)

FDA approved October 2006

This drug is approved for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

Zolinza was approved as part of FDA's Orphan Drug program, which offers companies financial incentives to develop medications for diseases affecting fewer than 200,000 American patients a year.

Evidence of Zolinza's safety and effectiveness was developed in two clinical trials with 107 CTCL patients who received Zolinza after their disease had recurred following other treatments. A response, defined by improvements on a scale that scores skin lesions, occurred in 30 percent of patients who received Zolinza and lasted an average of 168 days.  The most common serious adverse events were pulmonary embolism (blood clot in the lungs), dehydration, deep vein thrombosis and anemia. The most common other adverse events were gastrointestinal symptoms (including diarrhea, nausea, anorexia, vomiting and constipation); fatigue; chills; and taste disorders.

Zolinza has not been studied in pregnant women, but results of animal studies suggest that the drug may cause fetal harm when administered during pregnancy.

Aldara (imiquimod)

FDA approved July 1997

This topical cream was initially approved for the treatment of actinic keratosis and external genital warts. Now, it's approved for the treatment of superficial basal cell carcinoma (sBCC), a type of skin cancer.

This type of skin cancer is diagnosed by a healthcare provider after biopsy and is different from other types of skin cancer including other types of basal cell carcinoma.

Superficial basal cell carcinoma is usually treated by surgical removal. Aldara should be used for treatment of sBCC only when surgery is medically less appropriate, because the chances of effectively treating sBCC are generally greater with surgery. Patients treated with Aldara for sBCC should have regular follow-up visits after treatment to make sure the skin cancer is completely treated.

The safety and effectiveness of Aldara were established in two double-blind controlled studies with approximately 364 patients. In these studies, 75 percent of patients (139/185) who had their sBCC treated with Aldara had no evidence clinically or on repeat biopsy of their sBCC at 12 weeks after finishing treatment. In a separate long-term study involving 182 patients, 79 percent of patients had no evidence of their sBCC at two years after finishing treatment.

Most patients using Aldara Cream for the treatment of sBCC experienced skin reactions at the treatment site, which include redness, swelling, a sore or blister, peeling, itching, and burning.

 

 

 
Related Items
Wellness Library
  Medical Symptoms You Should Never Ignore
Cancer Source
  What To Do When You Find a Skin Abnormality
  How Can I Prevent or Detect Skin Cancer?
  Can I Get Checked for Nonmelanoma Skin Cancer?
  What Are the Symptoms of Nonmelanoma Skin Cancer?
  Understanding Your Stage of Nonmelanoma Skin Cancer
  What to Know About Surgery for Nonmelanoma Skin Cancer
  What to Know About Radiation Therapy for Nonmelanoma Skin Cancer
  What to Know About Chemotherapy for Nonmelanoma Skin Cancer
  Do What You Can to Ease Side Effects of Treatment for Nonmelanoma Skin Cancer
  Sunscreen and Skin Cancer
  Understanding the Types of Skin Cancer
  I’ve Just Been Told I Have Nonmelanoma Skin Cancer
  What Is My Prognosis for Nonmelanoma Skin Cancer?
  Am I At Risk for nonMelanoma Skin Cancer?
  Tips for Feeling Your Best During and After Treatment for Nonmelanoma Skin Cancer
Cancer FAQs
  Frequently Asked Questions About Nonmelanoma Skin Cancer
NCI Patient Summary
  Skin Cancer Prevention (PDQ®)
  Skin Cancer Treatment (PDQ®)
  Skin Cancer Screening (PDQ®)
Adult Diseases and Conditions
  Treatment for Skin Cancer
  Skin Cancer
  Basal Cell Carcinoma
  Causes of Skin Cancer
  Glossary - Skin Cancer
  Home Page - Skin Cancer
  Online Resources - Skin Cancer
  Other Causes and Risk Factors For Skin Cancer
  Preventing Skin Cancer
  Topic Index - Skin Cancer
  Facts About Skin Cancer
  Types of Skin Cancer
Pediatric Diseases and Conditions
  Skin Cancer in Children
  Treatment for Skin Cancer in Children